Moraxella catarrhalis strains with reduced expression of the UspA outer membrane proteins belong to a distinct subpopulation.

[1]  C. Aebi,et al.  SalivaryAntibodies Directed against Outer Membrane Proteins ofMoraxella catarrhalis in HealthyAdults , 2003, Infection and Immunity.

[2]  C. Aebi,et al.  Mucosal immune response to specific outer membrane proteins of Moraxella catarrhalis in young children , 2003, The Pediatric infectious disease journal.

[3]  G. Syrogiannopoulos,et al.  The outer membrane proteins UspA1 and UspA2 of Moraxella catarrhalis are highly conserved in nasopharyngeal isolates from young children. , 2002, Vaccine.

[4]  A. Takala,et al.  Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life , 2001, The Pediatric infectious disease journal.

[5]  P. Berche,et al.  Microbiology of otitis media in the Paris, France, area from 1987 to 1997. , 2001, The Pediatric infectious disease journal.

[6]  Wei-Gang Hu,et al.  Functional Characteristics of a Protective Monoclonal Antibody against Serotype A and C Lipooligosaccharides from Moraxella catarrhalis , 2001, Infection and Immunity.

[7]  E. Hansen,et al.  Expression of the Moraxella catarrhalisUspA1 Protein Undergoes Phase Variation and Is Regulated at the Transcriptional Level , 2001, Journal of bacteriology.

[8]  J. Dankert,et al.  Multiple Mechanisms of Phase Variation of PorA inNeisseria meningitidis , 2000, Infection and Immunity.

[9]  E. Hoiczyk,et al.  Structure and sequence analysis of Yersinia YadA and Moraxella UspAs reveal a novel class of adhesins , 2000, The EMBO journal.

[10]  G. Syrogiannopoulos,et al.  Antimicrobial use and colonization with erythromycin-resistant Streptococcus pneumoniae in Greece during the first 2 years of life. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  T. Murphy,et al.  Immune response to surface protein A of Streptococcus pneumoniae and to high-molecular-weight outer membrane protein A of Moraxella catarrhalis in children with acute otitis media. , 2000, The Journal of infectious diseases.

[12]  F. Mooi,et al.  Analysis of Moraxella catarrhalis by DNA typing: evidence for a distinct subpopulation associated with virulence traits. , 2000, The Journal of infectious diseases.

[13]  C. Slaughter,et al.  Characterization of the Moraxella catarrhalis uspA1 and uspA2 Genes and Their Encoded Products , 1999, Journal of bacteriology.

[14]  M. Gipson,et al.  Phase variation of HpuAB and HmbR, two distinct haemoglobin receptors of Neisseria meningitidis DNM2 , 1999, Molecular microbiology.

[15]  Dexiang Chen,et al.  The Levels and Bactericidal Capacity of Antibodies Directed against the UspA1 and UspA2 Outer Membrane Proteins ofMoraxella (Branhamella) catarrhalis in Adults and Children , 1999, Infection and Immunity.

[16]  T. Russo,et al.  Use of an Isogenic Mutant Constructed inMoraxella catarrhalis To Identify a Protective Epitope of Outer Membrane Protein B1 Defined by Monoclonal Antibody 11C6 , 1999, Infection and Immunity.

[17]  J. Gilsdorf.  Antigenic Diversity and Gene Polymorphisms inHaemophilus influenzae , 1998, Infection and Immunity.

[18]  Dexiang Chen,et al.  Isolation and Characterization of Two Proteins fromMoraxella catarrhalis That Bear a Common Epitope , 1998, Infection and Immunity.

[19]  E. Hansen,et al.  Phenotypic Effect of Isogenic uspA1 anduspA2 Mutations on Moraxella catarrhalis 035E , 1998, Infection and Immunity.

[20]  C. Slaughter,et al.  Mapping of a Protective Epitope of the CopB Outer Membrane Protein of Moraxella catarrhalis , 1998, Infection and Immunity.

[21]  T. Murphy.  Lung infections. 2. Branhamella catarrhalis: epidemiological and clinical aspects of a human respiratory tract pathogen. , 1998, Thorax.

[22]  S. E. Thomas,et al.  A protective epitope of Moraxella catarrhalis is encoded by two different genes , 1997, Infection and immunity.

[23]  T. Murphy,et al.  Antigenic heterogeneity and molecular analysis of CopB of Moraxella (Branhamella) catarrhalis , 1997, Infection and immunity.

[24]  M. Maiden,et al.  Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design , 1996, Clinical and diagnostic laboratory immunology.

[25]  J. Eldridge,et al.  Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization , 1996, Infection and immunity.

[26]  Ende,et al.  Variable expression of class 1 outer membrane protein in Neisseria meningitidis is caused by variation in the spacing between the -10 and -35 regions of the promoter , 1995, Journal of bacteriology.

[27]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[28]  E. Hansen,et al.  A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies. , 1994, The Journal of infectious diseases.

[29]  J. Cannon,et al.  Variation in expression of class 1 and class 5 outer membrane proteins during nasopharyngeal carriage of Neisseria meningitidis , 1990, Infection and immunity.

[30]  T. Murphy,et al.  Comparison of the outer membrane proteins of 50 strains of Branhamella catarrhalis. , 1988, The Journal of infectious diseases.

[31]  A. Verghese,et al.  Branhamella catarrhalis respiratory infections. , 1987, Reviews of infectious diseases.

[32]  K. Reisinger,et al.  Quantitative cultures of middle-ear fluid in acute otitis media. , 1983, The Journal of pediatrics.

[33]  G. V. Van Hare,et al.  Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media. , 1983, Pediatric infectious disease.